Ray Dalio's GSK Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 1.4 M shares of GSK plc (GSK) worth $60.5 M, representing 0.24% of the portfolio. First purchased in 2022-Q3, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in GSK, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2024, adding 1.28 M shares. Largest reduction occurred in Q1 2025, reducing 1.04 M shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's GSK plc (GSK) Holding Value Over Time
Track share changes against reported price movement
Quarterly GSK plc (GSK) Trades by Ray Dalio
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2022 | +87,661 | New Buy | 87,661 | $29.43 |
| Q4 2022 | +45,317 | Add 51.70% | 132,978 | $35.14 |
| Q1 2023 | +21,674 | Add 16.30% | 154,652 | $35.58 |
| Q2 2023 | +36,485 | Add 23.59% | 191,137 | $35.64 |
| Q3 2023 | -13,099 | Reduce 6.85% | 178,038 | $36.25 |
| Q4 2023 | +35,982 | Add 20.21% | 214,020 | $37.06 |
| Q1 2024 | -78,726 | Reduce 36.78% | 135,294 | $42.87 |
| Q2 2024 | +330,532 | Add 244.31% | 465,826 | $38.50 |
| Q3 2024 | +500,010 | Add 107.34% | 965,836 | $40.88 |
| Q4 2024 | +1.28 M | Add 132.72% | 2.25 M | $33.82 |
| Q1 2025 | -1.04 M | Reduce 46.47% | 1.2 M | $38.74 |
| Q2 2025 | +140,947 | Add 11.72% | 1.34 M | $38.40 |
| Q3 2025 | +57,713 | Add 4.29% | 1.4 M | $43.16 |
Ray Dalio's GSK plc Investment FAQs
Ray Dalio first purchased GSK plc (GSK) in Q3 2022, acquiring 87,661 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held GSK plc (GSK) for 13 quarters since Q3 2022. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's largest addition to GSK plc (GSK) was in Q4 2024, adding 2,247,691 shares worth $76.02 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 1,401,755 shares of GSK plc (GSK), valued at approximately $60.5 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, GSK plc (GSK) represents approximately 0.24% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio's peak holding in GSK plc (GSK) was 2,247,691 shares, as reported at the end of Q4 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.